Skip to content
Search

Latest Stories

Hub and spoke changes will not come into effect as scheduled

Hub and spoke changes will not come into effect as scheduled

“If pharmacies are to be able to benefit from the hub and spoke arrangements, new clinical services must be commissioned”- says CCA 

The Department of Health and Social Care (DHSC) has notified Community Pharmacy England (CPE) that they will no longer be able to implement the new hub and spoke models from 1 January 2025 as initially planned.

The delay comes after the General Election, which put the progress of these amendments on hold.


The DHSC is currently briefing new ministers across all policy areas, including hub and spoke dispensing between different pharmacy owners.

As this process will take time, the implementation will not proceed as originally scheduled.

CPE has stated that it does not yet have a clear timeline and will provide an update to the sector once more information becomes available.

Malcolm Harrison, CEO of the Company Chemists’ Association (CCA), expressed disappointment over the continued delays in fulfilling commitments made in the 2019 contractual framework agreement to support pharmacies.

He said: “As part of the 2019 five-year deal, community pharmacy has had to make substantial efficiency savings.  In exchange, the Department for Health and NHS England committed to enable more efficient operating models with changes to supervision and hub and spoke laws.”

Harrison highlighted that for pharmacies to be able to benefit from the hub and spoke arrangements, it is essential to commission new clinical services.

“The costs of establishing and maintaining hub operations are significant, and with little to no profit available in dispensing NHS medicines, it is hard to see how new facilities could be established, or pharmacies could afford to procure assembly services from them.

Ultimately, policymakers must realise that community pharmacy needs a ‘new deal’ – one that involves an increase in core funding and investment in new clinical services, such as Pharmacy First,” he added.

In 2022, the DHSC launched a consultation on the hub and spoke dispensing, proposing legislative changes to enable this practice across different legal entities.

The consultation outlined two potential models: Model 1, where patients would interact only with the spoke pharmacy, and Model 2, which would allow the hub to dispense medicines directly to patients on behalf of the spoke pharmacy.

In May 2024, the government confirmed the next steps following the consultation, announcing that the proposed legislative amendments would come into force on 1 January 2025, subject to the approval of the statutory instrument by the Houses of Parliament and the Northern Ireland Assembly.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less